Literature DB >> 19797284

Maternal and neonatal herpes simplex virus infections.

Lawrence Corey1, Anna Wald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19797284      PMCID： PMC2780322          DOI： 10.1056/NEJMra0807633

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  46 in total

1.  Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.

Authors:  W M Sullender; L L Yasukawa; M Schwartz; L Pereira; P A Hensleigh; C G Prober; A M Arvin
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

2.  Progesterone increases susceptibility and decreases immune responses to genital herpes infection.

Authors:  Charu Kaushic; Ali A Ashkar; Lesley A Reid; Kenneth L Rosenthal
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2.

Authors:  Tomio Miyai; Katherine R Turner; Charlotte K Kent; Jeffrey Klausner
Journal:  Sex Transm Dis       Date:  2004-09       Impact factor: 2.830

4.  Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.

Authors:  Anna Wald; Meei-Li Huang; David Carrell; Stacy Selke; Lawrence Corey
Journal:  J Infect Dis       Date:  2003-10-31       Impact factor: 5.226

Review 5.  Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review.

Authors:  Jeanne S Sheffield; Lisa M Hollier; James B Hill; Gretchen S Stuart; George D Wendel
Journal:  Obstet Gynecol       Date:  2003-12       Impact factor: 7.661

6.  Neonatal genital herpes simplex virus type 1 infection after Jewish ritual circumcision: modern medicine and religious tradition.

Authors:  Benjamin Gesundheit; Galia Grisaru-Soen; David Greenberg; Osnat Levtzion-Korach; David Malkin; Martin Petric; Gideon Koren; Moshe D Tendler; Bruria Ben-Zeev; Amir Vardi; Ron Dagan; Dan Engelhard
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

7.  Vidarabine therapy of neonatal herpes simplex virus infection.

Authors:  R J Whitley; A J Nahmias; S J Soong; G G Galasso; C L Fleming; C A Alford
Journal:  Pediatrics       Date:  1980-10       Impact factor: 7.124

8.  An evaluation of a rapid real time polymerase chain reaction assay for detection of group B streptococcus as part of a neonatal group B streptococcus prevention strategy.

Authors:  Deborah Money; Simon Dobson; Lesley Cole; Eda Karacabeyli; Edith Blondel-Hill; Ruth Milner; Eva Thomas
Journal:  J Obstet Gynaecol Can       Date:  2008-09

9.  Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.

Authors:  Zane A Brown; Anna Wald; R Ashley Morrow; Stacy Selke; Judith Zeh; Lawrence Corey
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Authors:  Lawrence Corey; Anna Wald; Raj Patel; Stephen L Sacks; Stephen K Tyring; Terri Warren; John M Douglas; Jorma Paavonen; R Ashley Morrow; Karl R Beutner; Leonid S Stratchounsky; Gregory Mertz; Oliver N Keene; Helen A Watson; Dereck Tait; Mauricio Vargas-Cortes
Journal:  N Engl J Med       Date:  2004-01-01       Impact factor: 91.245
View more
  99 in total

1.  Glutamine synthetase in newborn mice homozygous for lethal albino alleles.

Authors:  S Gluecksohn-Waelsch; M B Schiffman
Journal:  Dev Biol       Date:  1975-08       Impact factor: 3.582

2.  Answering questions about herpes in pregnancy.

Authors:  Stacey Wood
Journal:  J Perinat Educ       Date:  2011

3.  Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.

Authors:  Martin P Däumer; Beate Schneider; Doris M Giesen; Sheriff Aziz; Rolf Kaiser; Bernd Kupfer; Karl E Schneweis; Jens Schneider-Mergener; Ulrich Reineke; Bertfried Matz; Anna M Eis-Hübinger
Journal:  Med Microbiol Immunol       Date:  2010-10-08       Impact factor: 3.402

4.  Development and Validation of a Laboratory-Developed Multiplex Real-Time PCR Assay on the BD Max System for Detection of Herpes Simplex Virus and Varicella-Zoster Virus DNA in Various Clinical Specimens.

Authors:  Sylvie Pillet; Paul O Verhoeven; Amélie Epercieux; Thomas Bourlet; Bruno Pozzetto
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

Review 5.  Neonatal Herpes Simplex Virus Type 1 Infection and Jewish Ritual Circumcision With Oral Suction: A Systematic Review.

Authors:  Brian F Leas; Craig A Umscheid
Journal:  J Pediatric Infect Dis Soc       Date:  2014-07-23       Impact factor: 3.164

6.  Predominant area of brain lesions in neonates with herpes simplex encephalitis.

Authors:  H Kidokoro; L S de Vries; C Ogawa; Y Ito; A Ohno; F Groenendaal; S Saitoh; A Okumura; Y Ito; J Natsume
Journal:  J Perinatol       Date:  2017-07-20       Impact factor: 2.521

7.  Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation.

Authors:  Sarah J Kopp; Andrew H Karaba; Laura K Cohen; Ghazal Banisadr; Richard J Miller; William J Muller
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

8.  Neonatal herpes simplex virus infection.

Authors:  Thomas L Cherpes; Dean B Matthews; Samantha A Maryak
Journal:  Clin Obstet Gynecol       Date:  2012-12       Impact factor: 2.190

9.  The impact of brief messages on HSV-2 screening uptake among female defendants in a court setting: a randomized controlled trial utilizing prospect theory.

Authors:  Alexis M Roth; Barbara Van Der Pol; J Dennis Fortenberry; Brian Dodge; Michael Reece; David Certo; Gregory D Zimet
Journal:  J Health Commun       Date:  2014-12-12

10.  2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.

Authors:  Mårten Strand; Koushikul Islam; Karin Edlund; Christopher T Oberg; Annika Allard; Tomas Bergström; Ya-Fang Mei; Mikael Elofsson; Göran Wadell
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.